ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  Related Studies  
Improving Functional Outcomes in Patients With Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging

This study is currently recruiting participants.
Verified by Memorial Sloan-Kettering Cancer Center, July 2008

Sponsors and Collaborators: Memorial Sloan-Kettering Cancer Center
GARBAN FUND
Information provided by: Memorial Sloan-Kettering Cancer Center
ClinicalTrials.gov Identifier: NCT00597844
  Purpose

The purpose of this study is to see how the brain re-learns to control the larynx in speaking and swallowing when undergoing surgical rehabilitation in the form of either thyroplasty or vocal fold augmentation for unilateral vocal cord paralysis. What is needed is information on how the brain re-learns to control speaking and swallowing so that we can eventually learn how to help patients re-learn faster after their procedure. Functional Magnetic Resonance Imaging (or fMRI) will allow us to image your brain as you speak and swallow. We will produce "brain maps" for speaking, swallowing and hand movements.


Condition Intervention
Intrathoracic Malignancies
Unilateral Vocal Cord Paralysis
Other: voice evaluation and fMRI
Other: undergo voice evaluation and fMRI prior

MedlinePlus related topics:   Cancer    MRI Scans    Paralysis   

U.S. FDA Resources

Study Type:   Interventional
Study Design:   Diagnostic, Open Label, Parallel Assignment
Official Title:   Improving Functional Outcomes in Patients With Unilateral Vocal Cord Paralysis: Assessment of Adaptation Using Functional Magnetic Resonance Imaging

Further study details as provided by Memorial Sloan-Kettering Cancer Center:

Primary Outcome Measures:
  • utilize fMRI techn to characterize adaptation to alterations in vocal cord morphology, speech & swallowing function in patients with UVCP who will be undergoing proced for rehab of speech and swallowing, either type I thyroplasty or vocal fold augmen [ Time Frame: conclusion of study ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • is to develop a better understanding of central sensory motor reorganization in a response to both a peripheral injury to the speech and swallowing mechanism and surgical repair of the speech and swallowing mechanism. [ Time Frame: conclusion of study ] [ Designated as safety issue: Yes ]

Estimated Enrollment:   48
Study Start Date:   July 2005
Estimated Study Completion Date:   July 2009
Estimated Primary Completion Date:   July 2009 (Final data collection date for primary outcome measure)

Arms Assigned Interventions
1: Experimental
voice evaluation and fMRI prior to surgical rehabilitation of UVCP
Other: voice evaluation and fMRI
will undergo voice evaluation and fMRI prior to surgical rehabilitation of UVCP and in approximately one month and six months following treatment.
2
Healthy volunteers-voice evaluation and fMRI
Other: undergo voice evaluation and fMRI prior
in approximately one month and six months

Detailed Description:

The purpose of this investigation is to determine cortical mechanisms of adaptation to surgical rehabilitation of patients with unilateral vocal cord paralysis (UVCP) undergoing either type I thyroplasty or unilateral vocal fold augmentation for the management of unilateral vocal cord paralysis. This study will use the non-invasive imaging technique, Functional Magnetic Resonance Imaging (fMRI), to investigate cortical responses and responses in the larynx of patients with UVCP who have been deemed to be candidates for either type I thyroplasty or unilateral vocal fold augmentation for the purpose of rehabilitating this UVCP. Patterns of brain activity from the fMRI studies will be compared with the preoperative study with each patient serving as their own control for the purpose of evaluating the alterations in sensory motor organization of the brain in response to UVCP. In addition, responses in patients with UVCP will be compared to normal controls. This will allow us to identify the impact on speech and swallowing and the subsequent reorganization which we theorize will occur in response to the vocal cord medialization. Patients will undergo standardized voice evaluation with improvement in voice serving as a secondary endpoint. The results of the current investigation will provide needed information on both central and peripheral mechanisms of adaptation.

  Eligibility
Ages Eligible for Study:   18 Years to 85 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Patients with UVCP undergoing type I thyroplasty or vocal fold augmentation for rehabilitation of speech and swallowing.
  • Inclusion criteria for the healthy subjects:
  • From age 18-85

Exclusion Criteria:

  • for the UVCP patients includes the following:
  • History of significant psychiatric condition (e.g. schizophrenia, obsessive-compulsive disorder, significant dementia),
  • History of the following neurological conditions: CVA, seizure disorders, demyelinating conditions, systemic neuromuscular disorders, cerebral palsy, Alzheimer's disease.
  • History of previous moderate to severe traumatic brain injury.
  • History of significant cardiovascular, respiratory, gastrointestinal or renal disease (e.g. myocardial infarction within the previous 12 months, significant vaso-occlusive disease, severe or advanced asthma, COPD, emphysema, or renal compromise)
  • History of achalasia
  • History of dysphagia, odynophagia, or aphasia unrelated to present illness.
  • History of significant claustrophobic reactions.
  • Standard contraindications to MR examinations (e.g. implanted stimulators, pregnancy).

Exclusion criteria for the healthy subjects includes the following:

  • All of the conditions listed for the UVCP patients.
  • Significant surgery or previous radiation therapy to the head and neck.
  • History of other neoplasms involving the brain, head and neck, or gastrointestinal system.
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00597844

Contacts
Contact: Dennis Kraus, MD     krausd@mskcc.org    
Contact: Ryan Branski, PhD     branskir@mskcc.org    

Locations
United States, New York
Memorial Sloan Kettering Cancer Center     Recruiting
      New York, New York, United States, 10065
      Contact: Dennis Kraus, MD         krausd@mskcc.org    
      Contact: Ryan Branski, PhD         branskir@mskcc.org    
      Principal Investigator: Dennis Kraus, MD            

Sponsors and Collaborators
Memorial Sloan-Kettering Cancer Center
GARBAN FUND

Investigators
Principal Investigator:     Dennis Kraus, MD     Memorial Sloan-Kettering Cancer Center    
  More Information

Memorial Sloan-Kettering Cancer Center  This link exits the ClinicalTrials.gov site
 

Responsible Party:   Memorial Sloan-Kettering Cance Center ( Dennis Kraus, MD )
Study ID Numbers:   05-036
First Received:   January 9, 2008
Last Updated:   July 21, 2008
ClinicalTrials.gov Identifier:   NCT00597844
Health Authority:   United States: Institutional Review Board

Keywords provided by Memorial Sloan-Kettering Cancer Center:
type I thyroplasty  
unilateral vocal fold augmentation  

Study placed in the following topic categories:
Paralysis
Signs and Symptoms
Otorhinolaryngologic Diseases
Respiratory Tract Diseases
Vocal Cord Paralysis
Neurologic Manifestations
Laryngeal Diseases

Additional relevant MeSH terms:
Vagus Nerve Diseases
Nervous System Diseases
Cranial Nerve Diseases

ClinicalTrials.gov processed this record on August 29, 2008




Links to all studies - primarily for crawlers